Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Mobley, MD, on setting expectations and hydration protocols for the gemcitabine intravesical system
2
Pivotal phase 3 trial launches of rinzimetostat plus darolutamide in mCRPC
3
Richard Schlussel, MD, highlights emerging technologies in pediatric urology
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5